Under construction – not a live service
Sign in

What researchers published on Lung cancer

21,632 papers, newest first.

Showing 60 of 21,632

  • Intelligent Modular Dual-Readout Architecture Driven by CRISPR/Cas13a-CHA Cascade and Machine Learning for Portable Multiplex MicroRNA Liquid Biopsy in Early Lung Cancer.ACS sensors
  • Cryogenically Deposited Plasmonic Au Nanoparticle Films for Photothermal Treatment of Lung Cancer Cells.ACS omega
  • Longitudinal trajectories of peripheral blood lymphocyte subsets and PD-1 expression as dynamic prognostic markers in lung cancer.Frontiers in immunology
  • Case reportLattice radiotherapy followed by chemoimmunotherapy for sustained disease control in bulky centrally located left hilar lung squamous cell carcinoma: A case report.Medicine
  • Mechanisms of Resistance to KRAS G12C Inhibitors and the Rationale for Targeting the PI3K/AKT/mTOR Pathway in Advanced NSCLC.Mini reviews in medicinal chemistry
  • ReviewOptimizing Treatment Pathways With Multidisciplinary Team Discussions in Stage II to III NSCLC.JTO clinical and research reports
  • Reactive Oxygen Species Modulator 1 Promotes Tumor Progression and Angiogenesis via the ROS-HIF-1α Axis in Lung Adenocarcinoma.Cancer research and treatment
  • [Dual-port video-assisted lobectomy adapted for open surgery instruments].Khirurgiia
  • PRMT1 blockade reverts resistance to KRAS (G12C) inhibition through modulating ferroptosis signalling.International journal of oncology
  • Case reportLeser-Trélat sign associated with lung cancer: a case report and review of the literature.Frontiers in oncology
  • Case reportA Rare Case of Cutaneous Metastases From Lung Cancer.Cureus
  • RCAN2 attenuates lung cancer metastasis and thrombotic tendency by downregulating tissue factor via NFATC1/SNAI1 axis.Human cell
  • Inhalable nanoadjuvant augments STING activation for biomimetic immunotherapy and vaccination against lung cancer.Asian journal of pharmaceutical sciences
  • Digital Quantification of Stromal Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma: Associations With Histologic Grade and PET-Derived Metabolic Parameters.International journal of surgical pathology
  • Pathway Activity-Based Prognostic Risk Score Associated with Cisplatin Sensitivity in Small Cell Lung Cancer: Multi-Cohort Validation and Mechanistic Analysis.Current gene therapy
  • A Probability-Based Approach to Selecting Patients with Lung Cancer for Pretreatment Invasive Staging.Annals of the American Thoracic Society
  • METTL1-regulated tRF-5001b suppresses lung adenocarcinoma by impairing QARS1 interaction with tRNAGln and inhibiting HMGA2 translation.Non-coding RNA research
  • γ-Terpinene modulates an HLA-centered antigen processing and presentation network at the tuberculosis-lung cancer molecular interface: an integrated computational and experimental study.Journal of computer-aided molecular design
  • Glucagon-like peptide-1 receptor agonists and lung cancer risk in patients with type 2 diabetes and pulmonary nodules.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • ReviewNanomedicine-Enhanced CAR-Engineered Immunotherapy for Lung Cancer: Focusing on Multimodal Strategies and Precision Therapy.International journal of nanomedicine
  • Early Surgical Resection and Survival in Patients With Stage I Non-Small Cell Lung Cancer.JAMA network open
  • Observational studyEfficacy of Sunvozertinib in Heavily Pretreated Patients With EGFR-Mutated Non-Small Cell Lung Cancer: A Real-World Study.Cancer control : journal of the Moffitt Cancer Center
  • Impact of lung cancer screening on the workload of radiology professionals.Insights into imaging
  • Latent profiles of stigma and coping in lung cancer surgery patients: associations with quality of life.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
  • Inhalable ivermectin-loaded lipid-polymer hybrid nanoparticles as a promising anticancer platform for non-small cell lung cancer.Artificial cells, nanomedicine, and biotechnology
  • Reduced classical probiotic-associated butyrate biosynthetic potential predicts early primary resistance to anti-PD-1 therapy in advanced non-small cell lung cancer: a shotgun metagenomic study.Frontiers in cellular and infection microbiology
  • Development of a multidisciplinary service-delivery framework for venous thromboembolism prevention in hospitalized medical patients with lung cancer: a mixed-methods modified Delphi study.Frontiers in cardiovascular medicine
  • Dose-time-response relationships between radiation dose to the circulating blood and temporal changes in peripheral blood biomarkers during chemoradiation of non-small cell lung cancer.International journal of radiation oncology, biology, physics
  • Case reportWhen a left atrial mass is not a thrombus: pulmonary venous tumour extension in lung cancer.European heart journal. Case reports
  • Osimertinib, platinum, and etoposide for patients with metastatic EGFR/TP53/RB1-mutant lung cancers at risk for histological transformation.Science translational medicine
  • Prognostic value of pulmonary hypertension in lung cancer: a longitudinal cohort study.Clinical and experimental medicine
  • ReviewDeciphering the gut-lung axis in non-small cell lung cancer: from immune microenvironment crosstalk to clinical translation.Frontiers in oncology
  • The Au-TiO2 Janus Material Enables Integration of Serum Exosome Capture with Palmitoylated and Phosphorylated Peptide Enrichment for Non-Small Cell Lung Cancer Profiling.Analytical chemistry
  • Real-world surgical outcomes of segmentectomy vs. lobectomy in older adults with small stage IA NSCLC: long-term cancer-specific and competing mortality in an overlap-weighted SEER cohort.Frontiers in medicine
  • Case reportSMARCB1/INI1-deficient tumour of the thorax: a differential diagnosis to be included in thoracic basaloid tumours with ambiguous differentiation and review of the literature.Pathologica
  • Systematic reviewLocal Control Options for Metastatic Disease in Sarcoma.Current oncology reports
  • CIP2A drives lung adenocarcinoma by activating mitochondrial respiratory complexes IV and V.Cancer letters
  • [The clinical significance of macrophage migration inhibitory factor expression in serum and tissues of non-small cell lung cancer and its influence on the tumor microenvironment].Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • Case reportCase report and literature review: histologic transformation from EGFR-mutant lung adenocarcinoma to squamous cell carcinoma with newly detected SMAD4 and ATM variants.Frontiers in oncology
  • Co-alterations associated with resistance to EGFR inhibitors in advanced EGFR-positive NSCLC: insights from the precision oncology program in two large international real-world cohorts.NPJ precision oncology
  • Clinical And Radiological Predictors of Pathological Response to Chemo-Immunotherapy in Surgically Resected Non-Small Cell Lung Cancer.Clinical lung cancer
  • Repurposing of abemaciclib to overcome C797S-mediated osimertinib resistance in EGFR-mutant lung adenocarcinoma.Journal of biomedical science
  • Broad-Based Genomic Sequencing and Survival Outcomes in Advanced Non-Small Cell Lung Cancer: 2016-2022.Journal of the National Comprehensive Cancer Network : JNCCN
  • Quantitative and qualitative alteration in intracellular cholesterol status regulates statin sensitivity in non-small-cell lung cancer cells.Journal of pharmacological sciences
  • BL-DVDMS-mediated photodynamic therapy induces oxidative response associated with cellular senescence via p53/GADD45A signaling in lung cancer.Frontiers in pharmacology
  • Case reportSevere cutaneous adverse reaction to aumolertinib plus vebreltinib in an EGFR-mutant NSCLC patient: a case report.Frontiers in oncology
  • Fluorine-Functionalized Isophorone Near-Infrared Cu2+ Fluorescent Probe for Lung-Targeted Imaging of Diabetic Lung Injury and Lung Cancer.Journal of medicinal chemistry
  • Development of a Potent and Isoform-Selective HDAC11 Inhibitor with Anti-Tumor Efficacy against Non-Small Cell Lung Cancer.Journal of medicinal chemistry
  • A single-cell lung cancer atlas reveals cellular and molecular drivers of metastasis and clinical outcome.Nature cancer
  • Clinical study on the combined use of serum RHOXF1-AS1 and CT features to improve the accuracy of benign/malignant diagnosis and prognosis assessment in pulmonary nodules.Journal of cardiothoracic surgery
  • Perioperative ctDNA dynamics predict outcomes in resectable NSCLC using an ultrasensitive and cost-effective assay.NPJ precision oncology
  • Lung Adenocarcinoma With Extramedullary Hematopoiesis on ¹⁸F-FDG PET/CT: A Diagnostic Pitfall in Staging18F-FDG PET/CT.Clinical nuclear medicine
  • Spark-like T cell represents a novel functional state of CD8+T cells associated with anti-PD-1 immunotherapy response and clinical prognosis in non-small cell lung cancer.Frontiers in immunology
  • Density dependence and evolvability limit adaptive therapy in non-small cell lung cancer mouse model.Scientific reports
  • Interpreting and Validating a Deep Learning Model Predictive of Spatial Morphologic-Molecular Patterns in Lung Adenocarcinoma, Using Ground Truth Immunohistochemistry Images.The American journal of pathology
  • ReviewBeyond platinum sensitivity: immune-engaging therapies and multidimensional treatment stratification in relapsed small-cell lung cancer.Frontiers in immunology
  • A Cuproptosis Nanoparticle Reverses Lung Adenocarcinoma Drug Resistance.Exploration (Beijing, China)
  • Comment on 'The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR-TKIs treatment'.British journal of clinical pharmacology
  • Circ_0070354 promotes non-small cell lung cancer progression through the miR-1231/GPX4 axis and is associated with ferroptosis-related oxidative changes.Journal of molecular histology
  • Centromere-Targeting Chimeras for Combating Cancer Drug Resistance.Journal of medicinal chemistry